Drug profile

The FDA adverse-event record for Dasuquin Advanced

53 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Dasuquin Advanced. See the species affected, top reactions, and outcomes below.

53
adverse-event reports
15.1%
death-coded share
Dog
most-reported species
7
Urinary tract infection - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
53
Total Reports
8
Deaths Reported
15.1%
Death Rate

Active Ingredients

Dasuquin Advanced

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 46
Cat 7

Most Affected Breeds

Retriever - Labrador 15
Domestic Shorthair 5
Shepherd Dog - German 5
Retriever - Golden 3
Pointing Dog - German Short-haired 2
Crossbred Canine/dog 2
Setter - Irish Red 2
Siberian Husky 2
Terrier - Yorkshire 2
Beagle 1

Most Reported Reactions

Urinary tract infection 7
Vomiting 7
Death by euthanasia 6
Diarrhoea 5
Seizure NOS 5
Partial lack of efficacy 5
Decreased appetite 4
Polyuria 4
Polydipsia 4
Elevated alanine aminotransferase (ALT) 3
Mass NOS 3
Lack of efficacy - NOS 3

Outcome Breakdown

Ongoing
30 (56.6%)
Outcome Unknown
10 (18.9%)
Euthanized
6 (11.3%)
Recovered/Normal
5 (9.4%)
Died
2 (3.8%)

Dasuquin Advanced Adverse Event Insights

53 reports name Dasuquin Advanced; 8 recorded a death outcome (15.1% of reported events, not a population-level mortality rate). Active ingredient: Dasuquin Advanced. Administration routes: Unknown, Oral, Subcutaneous.

By species: Dog (46 reports), Cat (7 reports). By breed: Retriever - Labrador (15), Domestic Shorthair (5), Shepherd Dog - German (5).

Leading clinical signs: Urinary tract infection (7), Vomiting (7), Death by euthanasia (6), Diarrhoea (5). Outcome, 53 coded reports: Ongoing leads at 56.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.